Literature DB >> 19477416

Functional rescue of DeltaF508-CFTR by peptides designed to mimic sorting motifs.

Patrick Kim Chiaw1, Ling-Jun Huan, Stephane Gagnon, Diane Ly, Neil Sweezey, Daniela Rotin, Charles M Deber, Christine E Bear.   

Abstract

The cystic fibrosis (CF)-causing mutant, deltaF508-CFTR, is misfolded and fails to traffic out of the endoplasmic reticulum (ER) to the cell surface. Introduction of second site mutations that disrupt a diarginine (RXR)-based ER retention motif in the first nucleotide binding domain rescues the trafficking defect of deltaF508-CFTR, supporting a role for these motifs in mediating ER retention of the major mutant. To determine if these RXR motifs mediate retention of the native deltaF508-CFTR protein in situ, we generated peptides that mimic these motifs and should antagonize mistrafficking mediated via their aberrant exposure. Here we show robust rescue of deltaF508-CFTR in cell lines and in respiratory epithelial tissues by transduction of RXR motif-mimetics, showing that abnormal accessibility of this motif is a key determinant of mistrafficking of the major CF-causing mutant.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19477416     DOI: 10.1016/j.chembiol.2009.04.005

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  11 in total

1.  Phosphorylation-dependent C-terminal binding of 14-3-3 proteins promotes cell surface expression of HIV co-receptor GPR15.

Authors:  Yukari Okamoto; Sojin Shikano
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

2.  Human-mouse cystic fibrosis transmembrane conductance regulator (CFTR) chimeras identify regions that partially rescue CFTR-ΔF508 processing and alter its gating defect.

Authors:  Qian Dong; Lynda S Ostedgaard; Christopher Rogers; Daniel W Vermeer; Yuping Zhang; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-30       Impact factor: 11.205

3.  Probing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant.

Authors:  Wilson Yu; Patrick Kim Chiaw; Christine E Bear
Journal:  J Biol Chem       Date:  2011-05-21       Impact factor: 5.157

Review 4.  Current insights into the role of PKA phosphorylation in CFTR channel activity and the pharmacological rescue of cystic fibrosis disease-causing mutants.

Authors:  Stephanie Chin; Maurita Hung; Christine E Bear
Journal:  Cell Mol Life Sci       Date:  2016-10-08       Impact factor: 9.261

5.  The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis.

Authors:  Patrick H Thibodeau; John M Richardson; Wei Wang; Linda Millen; Jarod Watson; Juan L Mendoza; Kai Du; Sharon Fischman; Hanoch Senderowitz; Gergely L Lukacs; Kevin Kirk; Philip J Thomas
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

6.  Functional Rescue of F508del-CFTR Using Small Molecule Correctors.

Authors:  Steven Molinski; Paul D W Eckford; Stan Pasyk; Saumel Ahmadi; Stephanie Chin; Christine E Bear
Journal:  Front Pharmacol       Date:  2012-09-26       Impact factor: 5.810

Review 7.  Potential for therapeutic manipulation of the UPR in disease.

Authors:  Sang Won Park; Umut Ozcan
Journal:  Semin Immunopathol       Date:  2013-04-10       Impact factor: 9.623

8.  Use of kinase inhibitors to correct ΔF508-CFTR function.

Authors:  Agata M Trzcinska-Daneluti; Leo Nguyen; Chong Jiang; Christopher Fladd; David Uehling; Michael Prakesch; Rima Al-awar; Daniela Rotin
Journal:  Mol Cell Proteomics       Date:  2012-06-14       Impact factor: 7.381

9.  The B7-1 cytoplasmic tail enhances intracellular transport and mammalian cell surface display of chimeric proteins in the absence of a linear ER export motif.

Authors:  Yi-Chieh Lin; Bing-Mae Chen; Wei-Cheng Lu; Chien-I Su; Zeljko M Prijovich; Wen-Chuan Chung; Pei-Yu Wu; Kai-Chuan Chen; I-Chiao Lee; Ting-Yi Juan; Steve R Roffler
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

10.  Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance.

Authors:  Marco Rusnati; Davide Sala; Alessandro Orro; Antonella Bugatti; Gabriele Trombetti; Elena Cichero; Chiara Urbinati; Margherita Di Somma; Enrico Millo; Luis J V Galietta; Luciano Milanesi; Paola Fossa; Pasqualina D'Ursi
Journal:  Molecules       Date:  2018-01-08       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.